Exploring the extreme self-care trends shaping a generation of young men. I WAS IN NEW YORK having breakfast with a friend ...

Chewing-gum workouts for sharper jawlines. Specialty products for feathered bangs. So. Much. Cologne. An exploration of the aura-enhancing looksmaxxing self-care trends shaping an entire generation of ...

Some people will reference social media outright: ‘My profile looks bad in photos on Instagram ... my feed was flooded with ads for self-help products, including a workout routine designed ...

Eli Lilly's rare sales miss for weight-loss drug sends shares tumbling Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide ...

AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company, stands at a critical juncture as it navigates the loss of ...

Other AbbVie drugs, including its once-best-selling multiuse medication Humira, have been targeted by new provisions in the ...

The schizophrenia drug Emraclidine failed to perform in clinical trials but executives say it can still “play a role.” ...

Guggenheim analyst Vamil Divan lowered the firm’s price target on AbbVie (ABBV) to $212 from $221 and keeps a Buy rating on the shares. The ...

Leerink Partners analyst David Risinger has reiterated their bullish stance on ABBV stock, giving a Buy rating yesterday.Stay Ahead of the ...

Guggenheim Securities adjusted its financial outlook for shares of AbbVie Inc . (NYSE:ABBV), reducing the price target to $212 from the previous $221, while still recommending a Buy rating for the ...

It's encouraging to see that AbbVie has been growing its earnings per share at 5.7% a year over the past five years. While EPS is growing at a decent rate, but future growth could be limited by ...

AbbVie, with a market cap of over $300 billion, shows strong cash flow potential despite patent expirations, making it a valuable investment. The company reported strong 3Q financials, with ...